Endosialin and Associated Protein Expression in Soft Tissue Sarcomas: A Potential Target for Anti-Endosialin Therapeutic Strategies

Figure 5

Endosialin and PDGFR-β gene expression and outcomes in sarcoma histotypes. Endosialin ((a)–(d)) and PDGFR-β ((e)–(h)) expression versus overall survival in different histological subtypes of sarcoma. (a) and (e) Undifferentiated (); (b) and (f) leiomyosarcoma (); (c) and (g) other (angiosarcoma and synovial sarcoma) (); and (d) and (h) liposarcoma ().

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)